Compared to placebo (3.3%, 3.2 kg), patients lost a mean of 13.4% (13.5 kg) of body weight in the 10 mg group and 15.7% (15.6 kg) of body weight in the 15 mg group
Medications that directly cross the blood-brain barrier and interact with neurotransmitter systemsparticularly those involving serotonin, norepinephrine, dopamine, acetylcholine, and gamma-aminobutyric acid (GABA)are most likely to affect sleep architecture and dream content
Flow Wellness recommends monitoring the area and contacting your provider if the lump grows, becomes painful, or persists
For instance, if nausea, vomiting or constipation lasts for more than a few days without improvement, or if you experience unintentional weight loss beyond what is expected from GLP-1s appetite-suppressing effects, it could signal a more serious issue, says Salhab
For a deeper exploration of this comparison, TRT Nations blog post The Most Effective GLP-1/GIP Weight Loss therapies provides additional clinical context and guidance